Matches in Wikidata for { <http://www.wikidata.org/entity/Q73888825> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q73888825 description "artículu científicu espublizáu n'ochobre de 1997" @default.
- Q73888825 description "bài báo khoa học" @default.
- Q73888825 description "im Oktober 1997 veröffentlicher wissenschaftlicher Artikel" @default.
- Q73888825 description "scientific article published on 01 October 1997" @default.
- Q73888825 description "wetenschappelijk artikel" @default.
- Q73888825 description "наукова стаття, опублікована в жовтні 1997" @default.
- Q73888825 name "Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study" @default.
- Q73888825 name "Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study" @default.
- Q73888825 type Item @default.
- Q73888825 label "Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study" @default.
- Q73888825 label "Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study" @default.
- Q73888825 prefLabel "Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study" @default.
- Q73888825 prefLabel "Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study" @default.
- Q73888825 P1433 Q73888825-88142B71-9F2C-4A78-82FD-E8348D7BEB53 @default.
- Q73888825 P1476 Q73888825-7FF64C0F-E767-410C-959F-23CBFE406507 @default.
- Q73888825 P2093 Q73888825-1EFF48EB-321E-4607-AC20-443C705C4037 @default.
- Q73888825 P2093 Q73888825-5F08D5B9-1C39-4A27-B781-4C0C4EB09655 @default.
- Q73888825 P2093 Q73888825-7D96D32D-70D9-4EDE-9CB8-A96DE0AD93F9 @default.
- Q73888825 P2093 Q73888825-96BD892A-1DEA-4FBF-A9FF-853D8987B688 @default.
- Q73888825 P2093 Q73888825-BE56760A-C966-442A-A664-A287D5B70FB4 @default.
- Q73888825 P2093 Q73888825-CF44DC63-CACD-460D-B6A7-FD850A540E37 @default.
- Q73888825 P304 Q73888825-D01CE2F2-8F7A-4342-A810-D7C810653388 @default.
- Q73888825 P31 Q73888825-85F57B0B-6580-47A8-9782-26E1415AA6C6 @default.
- Q73888825 P433 Q73888825-05B60211-46FF-4A1E-AD83-2D89F7D7585C @default.
- Q73888825 P478 Q73888825-E72633B6-8E8C-495F-ACB1-441C19C77790 @default.
- Q73888825 P577 Q73888825-95CFE87F-800D-47E9-B94B-8D6B913C0240 @default.
- Q73888825 P698 Q73888825-F79DF832-25D5-48EC-92CD-F6E73187876C @default.
- Q73888825 P921 Q73888825-732929A9-AA09-4BFC-B024-64A87810A584 @default.
- Q73888825 P921 Q73888825-C7BE0724-3BAA-4BEB-90FE-A6D18ACB72FB @default.
- Q73888825 P698 9374091 @default.
- Q73888825 P1433 Q14330412 @default.
- Q73888825 P1476 "Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study" @default.
- Q73888825 P2093 "Fuechsel G" @default.
- Q73888825 P2093 "Kettner E" @default.
- Q73888825 P2093 "Köhler U" @default.
- Q73888825 P2093 "Olbricht SS" @default.
- Q73888825 P2093 "Richter B" @default.
- Q73888825 P2093 "Ridwelski K" @default.
- Q73888825 P304 "S17-40-S17-43" @default.
- Q73888825 P31 Q13442814 @default.
- Q73888825 P433 "5 Suppl 17" @default.
- Q73888825 P478 "24" @default.
- Q73888825 P577 "1997-10-01T00:00:00Z" @default.
- Q73888825 P698 "9374091" @default.
- Q73888825 P921 Q12859063 @default.
- Q73888825 P921 Q423762 @default.